OPRX Stock Summary and Trading Ideas (Optimizerx | NASDAQ:OPRX)

OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.

Optimizerx trades on the NASDAQ stock market under the symbol OPRX.

As of September 1, 2026, OPRX stock price declined to $7.86 with 113,237 million shares trading.

OPRX has a beta of 2.25, meaning it tends to be more sensitive to market movements. OPRX has a correlation of 0.16 to the broad based SPY ETF.

OPRX has a market cap of $145.33 million. This is considered a Micro Cap stock.

Last quarter Optimizerx reported $21 million in Revenue and $.16 earnings per share. This beat revenue expectation by $244,800 and exceeded earnings estimates by $.07.

In the last 3 years, OPRX traded as high as $22.25 and as low as $3.78.

The top ETF exchange traded funds that OPRX belongs to (by Net Assets): VTI, VXF, DFSV, IWC, ITOT.

OPRX has underperformed the market in the last year with a price return of -56.5% while the SPY ETF gained +19.3%. However, in the short term, OPRX had mixed performance relative to the market. It has outperformed in the last 3 months, returning +46.1% vs +0.7% return in SPY. But in the last 2 weeks, OPRX shares have been beat by the market, returning -4.5% compared to an SPY return of -0.7%.

OPRX support price is $7.68 and resistance is $8.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OPRX shares will trade within this expected range on the day.